Biobijou Co Ltd
489460
Company Profile
Business description
Biobijou Co Ltd is engaged in the development, manufacturing, and distribution of medical aesthetic products. It offers a comprehensive range of medical aesthetic products designed for professional use such as Hyaluronic Acid (HA) Dermal Fillers, Skin Boosters, Botulinum Toxin, Lipolysis Injections and others.
Contact
947 Hanam-daero
Building A, Room 1516
U1CENTER, Hanam Techno Valley, Pungsan-dong
Gyeonggi-do
Hanam-si
KORT: +82 262359696
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
37
Stocks News & Analysis
stocks
Hostile takeover on the cards for this ASX income opportunity
IFM lobs reasonable takeover offer.
stocks
Get ready for major US tech earnings starting tomorrow morning
Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks
Corning’s AI fiber boom is real, but its stock price may be getting out of hand
Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 16.00 | 0.18% |
| CAC 40 | 8,059.76 | 44.33 | -0.55% |
| DAX 40 | 23,990.90 | 27.36 | -0.11% |
| Dow JONES (US) | 49,141.93 | 25.86 | -0.05% |
| FTSE 100 | 10,251.93 | 80.86 | -0.78% |
| HKSE | 26,111.84 | 432.06 | 1.68% |
| NASDAQ | 24,663.80 | 223.30 | -0.90% |
| Nikkei 225 | 59,917.46 | 619.90 | -1.02% |
| NZX 50 Index | 12,770.30 | 5.90 | 0.05% |
| S&P 500 | 7,138.80 | 35.11 | -0.49% |
| S&P/ASX 200 | 8,687.00 | 9.40 | 0.11% |
| SSE Composite Index | 4,107.51 | 28.88 | 0.71% |